1969 - 1978
General Partner of Advent. Raj joined Advent in 2005, bringing over 20 years of experience as an entrepreneur and investor in the life sciences.
After an academic career in molecular medicine at Oxford University, Raj co-founded Oxford GlycoSciences which became listed on the LSE and NASDAQ. Following its sale to UCB-Celltech, he became Chairman of Chroma Therapeutics and of Galapagos nv, and a Director of Celldex Therapeutics before joining Advent. He has served on the Board of several portfolio Companies including Thiakis, Avila, EUSA and Cellnovo.
